BioFIT will host the 3rd edition of the “R&D dating for animal health and innovation”, initiated by the French association for animal health industry (SIMV) on 28th and 29th November 2017, in Strasbourg.

About the event

Today, public-private and private-private partnerships are thought to be the needed leverage for innovation. Hence, the SIMV (the French association for the animal health industry) launched the “R&D dating for Animal Health and innovation” which aims at initiating high-level exchanges between the research departments of the veterinary medicine and diagnostics industry and public research, as well as biotechnology companies (start-ups).

By enabling face-to-face encounters, the event will enhance the visibility of cutting-edge research in France and in Europe, encourage investments, and lead to therapeutic innovation.

About SIMV

While being the organiser of this meeting, the SIMV intends to federate research actors by actively contributing to meet the needs in animal health innovation. In particular, enhanced research is needed to supplement and renew the therapeutic arsenal for the treatment of infectious diseases and therefore research and innovation on this topic should be promoted.

Strong multi-disciplinary large-horizon partnerships are key to successful innovations for the future.

Join us for this very exciting event and drive tomorrow’s innovation !

LabEx Medalis conference
28th November 2017

BioFIT Exhibition hall |9:00 – 9:30 am


Session 1: Translational research at Medalis: From lab to biotech
Moderator : Robert ZIMMER | CEO ImmuPharma

Salon  5 Rome | Nov the 28th | 9:30 – 11:00 am

ImmuPharma, a successful pioneer in academic private intimate collaboration (Sylviane MULLER, Laboratory of Immunology and Therapeutic Chemistry UPR3572 CNRS, Robert ZIMMER, CEO ImmuPharma)

From the molecular dissection of signalling receptor transmembrane domains interaction in cancer(Dominique BAGNARD, The Microenvironmental Niche in tumorigenesis and targeted therapy INSERM U1109, Group Head) to Peptimimesis Pharma (Marjorie SIDHOUM, CEO)

From innovation in click chemistry (Alain WAGNER, Laboratory of Design and Application of Bioactive Molecules, UMR7199 CNRS-UdS, Group Head) to Syndivia (Sasha KONIEV, CEO)

From the development of a molecular tool predicting cancer drug efficacy, (Justine Fritz, Former PhD in Dominique BAGNARD group, MN3T lab) to Adaptherapy (Bertrand LOUBATON, CEO)


BioFIT Exhibition hall | 1:00 – 2:30 pm


Session 2: Early projects, early opportunity: Find your match
Moderator: Jean-Christophe Peter (Scientific Manager, Labex Medalis)
Salon  5 Rome | Nov the 28th | 2:30 – 4:00 pm

Development of a PPI inhibitor of the CDK4/cyclin D complex for cancer treatment (Frédéric BIHEL, Laboratory of therapeutic Innovation, UMR 7200 CNRS-UdS)

Preclinical validation of the therapeutic potential of MTP-PlexA1 in demyelination disease (Fabien BINAME, The Microenvironmental Niche in tumorigenesis and targeted therapy INSERM U1109)

Fluorospexin and Pain (Dominique BONNET, Laboratory of therapeutic Innovation, UMR 7200 CNRS-UdS, and Frédéric SIMONIN, GPCR, Pain and Inflammation, UMR 7242 CNRS-UdS)

Peptide P140 and asthma: Preclinical evaluation in relevant mouse models (Nelly FROSSARD, Laboratory of therapeutic Innovation, UMR 7200 CNRS-UdS)

Neutraligands of CXCL12 (Marcel HIBERT, Laboratory of therapeutic Innovation, UMR 7200 CNRS-UdS)

Nanostructured Carriers for Intelligent SiRNA co-delivery with anticancer drugs (Antoine KICHLER, Laboratory of Design and Application of Bioactive Molecules, UMR7199 CNRS-UdS)

A global and rational approach to PPI modulation (Didier ROGNAN, Laboratory of therapeutic Innovation, UMR 7200 CNRS-UdS)

MicroOmics: Deciphering cancer heterogeneity at the single cell multi-omic level (Sylvain URSUEGUI, Laboratory of Design and Application of Bioactive Molecules, UMR7199 CNRS-UdS)


BioFIT Exhibition hall | 4:00 – 4:30 pm


Session 3: Nature and nurture of an Academic drug discovery Centre
Moderator: Jean-Christophe Peter (Scientific Manager, Labex Medalis)

Salon  5 Rome | Nov the 28th | 4:30 – 6:00 pm

Round table:
> How developing a continuing research effort out of the box?
> How educating researchers at the interface of chemistry and biology?
> How involving industrial partners?
> The role of corporate sponsorship in such initiatives?


Pierre EFTEKHARI, INOVIEM Scientifique
Serge POTIER, University of Strasbourg
Jean GAGNEUX, CiRFC Foundation
Marcel HIBERT, Faculty of Pharmacy
Pascal NEUVILLE, Domain Therapeutics


From 6.30 pm …


One day before BioFIT event (on 27th November), Alsace BioValley and his partner BIOPRO Baden-Württemberg will organise their 14th Meet & Match, in Strasbourg, on the topic of « Strategies for drug discovery: Simulation – Screening – Repurposing ».

The event will cover a wide range of areas – from simulation, screening and target identification technologies to the repurposing of already known active ingredients / drugs.

Why participate to Meet&Match event?
Company representatives, project leaders from the health industry as well as academic researchers from both sides of the Rhine – France (Grand Est region) and Germany (Baden-Württemberg) – meet each other to generate new partnerships and joint developments.

This event will be a great opportunity for biotech companies, contract research organisations and academic labs to present and envision future approaches, which would match the pharma industry needs.